A New Jersey biostatistician is faced with federal charges after allegedly capitalizing on confidential information to turn a hefty profit, exceeding $450,000 through insider trading. Named in the indictment is Hong Wang, a 59-year-old from East Brunswick, whose arrest by federal authorities took place this morning, according to a press release from the U.S. Attorney's Office. Wang's upcoming court appearance will be held in Boston, with the date yet to be announced.
While Wang was employed as a consultant for a Massachusetts-based pharmaceutical company, referred to as Company A in the indictment, he purportedly came to quickly learn of material non-public information about an upcoming announcement concerning the positive test results for a cancer drug. The indictment alleges that, before these results were made public in December 2023, Wang proceeded to rapidly purchase over 150,000 shares of Company A stock through several brokerage accounts under his control, capitalizing on information not yet available to the masses.
Post the disclosure in December, Wang allegedly sold 20,000 shares, taking advantage of the surge in the stock's value, while holding on to the remainder. The profits from these transactions allegedly netted Wang more than $450,000 – an act defined as securities fraud, carrying a possible sentence of up to 20 years in prison and fines soaring up to $5 million.
In conjunction with these charges, the Securities and Exchange Commission has also launched a civil suit against Wang, affirming the legal troubles stemming from his dealings in the securities of Company A. United States Attorney Leah B. Foley, alongside FBI Special Agent in Charge Ted E. Docks of the Boston Division, announced the charges. The federal case is being prosecuted by Assistant U.S. Attorney Benjamin A. Saltzman, reported the U.S. Attorney's Office.
It's imperative to note that charges set forth in the indictment are strictly allegations at this point; Wang is presumed innocent until proven guilty in a court of law beyond a reasonable doubt. Further developments in this case are to be closely monitored as the judicial process unfolds.
